Geffner Michael sold IMVT

January 26, 2024 · Form 4 insider transaction

Geffner Michael sold 153 shares of Immunovant, Inc. at $38.45 per share, a transaction worth $5.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.

Direction
Disposed (sell-side)
Shares
153
Price
$38.45
Total value
$5.9K
Role
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 26, 2024
Filing dateJanuary 29, 2024
Shares owned after89,899
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

On January 17, 2023, the holder was granted 100,000 restricted stock units ("RSUs"), as previously reported on a Form 3 filed on January 16, 2024, of which 25,000 of these RSUs vested on January 17, 2024. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.; The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $38.45 - $38.50 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

View the original Form 4 on SEC EDGAR